Zhejiang NHU Company (002001) Q2 2026 earnings summary

Executive summary

• Operating revenue reached RMB 13.13 billion, up 18.28% year-over-year; net profit attributable to shareholders was RMB 4.01 billion, up 11.31% year-over-year.

• Growth driven by strong performance in nutrition segment, especially methionine, and stable sales in other segments.

• Key projects, including the Tianjin New Materials Nylon Industry Chain and PPS Phase IV, advanced as planned.

• Continued focus on innovation, digital transformation, and global expansion, with the Japan Research Institute completed.

Financial highlights

• Operating revenue: RMB 13,129,300,260.89 (up 18.28% YoY).

• Net profit attributable to shareholders: RMB 4,010,733,454.55 (up 11.31% YoY).

• Net cash flows from operating activities: RMB 3,640,144,282.94 (up 12.26% YoY).

• Basic and diluted EPS: RMB 1.30 (up 11.11% YoY).

• Total assets: RMB 46,685,231,500.76 (up 2.37% from Dec 31, 2025).

• Net assets attributable to shareholders: RMB 34,880,103,504.10 (up 6.32% from Dec 31, 2025).

Outlook and guidance

• Plans to accelerate internationalization, strengthen localized operations, and enhance global innovation and sales centers.

• Will continue to focus on R&D, product competitiveness, and digital transformation to drive sustainable growth.